MW2380A1 - Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation - Google Patents

Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation

Info

Publication number
MW2380A1
MW2380A1 MW23/80A MW2380A MW2380A1 MW 2380 A1 MW2380 A1 MW 2380A1 MW 23/80 A MW23/80 A MW 23/80A MW 2380 A MW2380 A MW 2380A MW 2380 A1 MW2380 A1 MW 2380A1
Authority
MW
MALAWI
Prior art keywords
preparation
ethers
pharmaceutical
intermediates therefor
intermediates
Prior art date
Application number
MW23/80A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MW2380A1 publication Critical patent/MW2380A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/74—Unsaturated compounds containing —CHO groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MW23/80A 1979-06-29 1980-06-27 Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation MW2380A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922781 1979-06-29

Publications (1)

Publication Number Publication Date
MW2380A1 true MW2380A1 (en) 1982-03-10

Family

ID=10506199

Family Applications (1)

Application Number Title Priority Date Filing Date
MW23/80A MW2380A1 (en) 1979-06-29 1980-06-27 Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation

Country Status (18)

Country Link
US (1) US4410537A (ko)
EP (1) EP0022229B1 (ko)
JP (1) JPS5649335A (ko)
KR (2) KR850000073B1 (ko)
AU (1) AU545274B2 (ko)
DE (1) DE3061269D1 (ko)
DK (1) DK159770C (ko)
FI (1) FI71929C (ko)
GB (1) GB2053218B (ko)
GR (1) GR68748B (ko)
HU (1) HU190774B (ko)
IL (1) IL60422A (ko)
IT (1) IT1133025B (ko)
MW (1) MW2380A1 (ko)
OA (1) OA06699A (ko)
ZA (1) ZA803880B (ko)
ZM (1) ZM5780A1 (ko)
ZW (1) ZW14480A1 (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64573A (en) * 1980-12-18 1985-04-30 Wellcome Found Derivatives of formylphenoxyalkanoic acids and formylphenoxymethylbenzoic acids,their preparation and pharmaceutical formulations containing them
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
US6083522A (en) 1997-01-09 2000-07-04 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
AU2622301A (en) * 1999-11-05 2001-05-14 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
EP1265840A2 (en) 2000-03-17 2002-12-18 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
MY175521A (en) 2011-01-07 2020-07-01 Allergan Inc Melanin modification compositions and methods of use
SI3141542T1 (sl) 2011-12-28 2020-11-30 Global Blood Therapeutics, Inc. Substituirane spojine benzaldehida in metode njihove uporabe pri povečanju oksigenacije tkiva
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN105246477A (zh) 2013-03-15 2016-01-13 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
CN105073728A (zh) * 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR101971385B1 (ko) 2013-03-15 2019-04-22 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US10800751B2 (en) * 2013-08-23 2020-10-13 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
EA028529B1 (ru) 2014-02-07 2017-11-30 Глобал Блад Терапьютикс, Инк. Кристаллические полиморфные формы свободного основания 2-гидрокси-6-((2-(1-изопропил-1н-пиразол-5-ил)пиридин-3-ил)метокси)бензальдегида
MY190034A (en) 2015-03-06 2022-03-22 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MX2018006832A (es) 2015-12-04 2018-11-09 Global Blood Therapeutics Inc Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido.
MX2018009413A (es) * 2016-02-08 2019-05-15 Beyondspring Pharmaceuticals Inc Composiciones que contienen tucaresol o sus analogos.
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3768264A4 (en) * 2018-03-22 2021-12-22 Virginia Commonwealth University AROMATIC ALDEHYDE WITH DELAYED AND IMPROVED PHARMACOLOGICAL IN-VITRO AND IN-VIVO ACTIVITY FOR TREATMENT OF SICKLE CELL DISEASE
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease
US10683285B2 (en) 2018-11-19 2020-06-16 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU36436A1 (ko) * 1958-04-30
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
CH550776A (de) 1971-03-05 1974-06-28 Ciba Geigy Ag Herstellung neuer bis-stilbenverbindungen.
DE2209128C3 (de) 1971-03-05 1981-10-22 CIBA-GEIGY AG, 4002 Basel Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller
GB1511645A (en) * 1974-05-31 1978-05-24 Univ Ife Sickle cell anaemia treatment
US4137309A (en) * 1976-10-14 1979-01-30 The Procter & Gamble Company Therapeutic treatment

Also Published As

Publication number Publication date
KR840004668A (ko) 1984-10-22
EP0022229A1 (en) 1981-01-14
GB2053218A (en) 1981-02-04
GR68748B (ko) 1982-02-16
EP0022229B1 (en) 1982-12-08
DE3061269D1 (en) 1983-01-13
KR830002693A (ko) 1983-05-30
KR850000073B1 (ko) 1985-02-18
IL60422A0 (en) 1980-09-16
IT8049108A0 (it) 1980-06-27
GB2053218B (en) 1984-01-25
OA06699A (fr) 1982-05-31
AU5969780A (en) 1981-01-08
FI71929B (fi) 1986-11-28
IL60422A (en) 1984-06-29
DK279780A (da) 1980-12-30
HU190774B (en) 1986-11-28
ZW14480A1 (en) 1982-03-17
JPH0154339B2 (ko) 1989-11-17
DK159770B (da) 1990-12-03
AU545274B2 (en) 1985-07-11
ZA803880B (en) 1982-02-24
US4410537A (en) 1983-10-18
JPS5649335A (en) 1981-05-02
FI71929C (fi) 1987-03-09
IT1133025B (it) 1986-07-09
ZM5780A1 (en) 1983-11-21
FI802052A (fi) 1980-12-30
KR850000072B1 (ko) 1985-02-18
DK159770C (da) 1991-04-22

Similar Documents

Publication Publication Date Title
MW2380A1 (en) Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation
EP0054924A3 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
IL50008A0 (en) 2',4-dichloro-4'-benzoylureido-diphenyl ethers,their preparation and their use as insecticides
IL61685A0 (en) Basic ethers,their preparation and pharmaceutical compositions containing them
DE3064823D1 (en) Pyridyl-2-oxy-phenyloxime ethers and esters, their preparation and their use as herbicides
DE3173607D1 (en) Imidazoazolalkenyl carboxamides, intermediates for their preparation, their preparation and their use as medicaments
IL60874A (en) Preparation of 4-fluoro-3-phenoxy-benzaldehyde,intermediates therefor and their preparation
IL60918A0 (en) 6-pyridayinones,their preparation and pharmaceutical compositions cosntaining them
DE3062268D1 (en) Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
ZA803855B (en) Fungicidal -triazolyl ethers, their manufacture and use
DE3375141D1 (en) Vinylthioacetamido oxacephalosporin derivatives, and intermediates therefor, their preparation, formulations containing the same and their antibacterial use
DE3062017D1 (en) Phenyliminothiazoline derivatives, their preparation and intermediates therefor, pharmaceutical preparations containing them and their production
DE3071198D1 (en) Acridinones, their preparation and use; intermediates and their preparation
IL60802A0 (en) N-pyrimidinylmethyl-halogenacetanilides,their preparation and their use as herbicides
IL54061A0 (en) New benzyloxime ethers,their preparation and their use as pesticides
DE3060100D1 (en) Omega-halogeno-acetophenone oxime ethers, preparation thereof and their use as intermediates in the preparation of omega-azolyl-acetophenone oxime ethers
EP0044954A3 (en) Anthracyclinglycosides, their preparation and intermediates, and pharmaceutical preparations
IL60729A0 (en) Imidazolyl-enol ethers,their preparation and their use as fungicides
DE2962784D1 (en) Isoquinoline compounds, their preparation, pharmaceutical formulations containing them and intermediates
DE2861930D1 (en) A-40104 antibiotics, their preparation, and formulations containing them
IL60730A0 (en) Imidazolyl-enol ethers,their preparation and their use as fungicides
DE3061280D1 (en) N,n-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof
DE3064852D1 (en) Nitrothiazolines, their preparation and pharmaceutical formulations containing them
DE3069781D1 (en) 2-amino-benzoic-acid derivatives, their preparation and their use as medicines or intermediates
DE2861018D1 (en) Lasalocide derivatives, their preparation and intermediates, and the pharmaceutical preparations containing them